Lei Huang1, Lina Jansen2, Rob H A Verhoeven3, Jelle P Ruurda4, Liesbet Van Eycken5, Harlinde De Schutter5, Jan Johansson6, Mats Lindblad7, Tom B Johannesen8, Vesna Zadnik9, Tina Žagar9, Margit Mägi10, Sjoerd M Lagarde11, Esther Bastiaannet12, Cornelis J H van de Velde12, Petra Schrotz-King13, Hermann Brenner14. 1. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, Heidelberg, 69120, Germany. 2. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. 3. Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands. 4. Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. 5. Belgian Cancer Registry (BCR), Brussels, Belgium. 6. Department of Esophageal and Gastric Surgery, Lund University Hospital, Lund, Sweden. 7. Department of Clinical Science, Intervention, and Technology (CLINTEC), Division of Surgery, Karolinska University Hospital, Stockholm, Sweden. 8. Registry Department, The Cancer Registry of Norway (CRN), Oslo, Norway. 9. Epidemiology and Cancer Registry, Institute of Oncology Ljubljana, Ljubljana, Slovenia. 10. Estonian Cancer Registry, National Institute for Health Development, Tallinn, Estonia. 11. Department of Surgery, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, The Netherlands. 12. Department of Surgical Oncology, Leiden University Medical Center, The Netherlands. 13. Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. 14. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, Heidelberg, Baden-Württemberg 69120, Germany.
Abstract
AIMS: The role of resection remains debated in cases of metastatic gastric carcinoma (mGC). Some mGCs are technically resectable. At the population level, the real-world application of resection for mGC remains largely unclear in most Western countries. This large, population-based international investigation aimed to reveal the resection patterns and trends for mGC and the treatment-associated factors in Europe and the US. METHODS: Data on cases with microscopically-confirmed primary invasive stomach carcinoma with distant metastasis were obtained from the nationwide cancer registries of the Netherlands, Belgium, Norway, Sweden, Estonia, and Slovenia and the US Surveillance, Epidemiology, and End Results-18 database. We calculated age-standardized rates of primary cancer-directed resection and assessed resection trends using linear regression. We investigated associations of treatment with patient and cancer factors using multivariable-adjusted log-binomial regression. RESULTS: Among 133,321 patients with gastric cancer, overall, 40,215 cases with mGC diagnosed between 2003-2017 were investigated. Age-standardized resection rates significantly declined over time in the US, Belgium, Sweden, and Norway (by 5-14%). Resection rates greatly differed from 5% to 16% in 2013-2014. Cases with older ages, cardia tumors, or tumors involving adjacent structures were significantly less often operated across most countries. Sex was not significantly associated with resection. Across countries the association patterns and strengths differed largely. With multivariable adjustment, resection rates decreased significantly in all countries except Slovenia and Estonia (prevalence ratio per year = 0.90-0.98), and the decreasing trends were consistently observed in various stratifications by age and location. CONCLUSION: In Europe and the US, resection patterns and trends largely varied across countries for mGCs, which were mostly less often resected in the early 21st century. Various resection-associated factors were shown, with greatly varying association patterns and strengths. Our report could aid to identify discrepancies in clinical practice and highlight the great need for further clarifying the role of resection in mGCs to enhance standardization of care.
AIMS: The role of resection remains debated in cases of metastatic gastric carcinoma (mGC). Some mGCs are technically resectable. At the population level, the real-world application of resection for mGC remains largely unclear in most Western countries. This large, population-based international investigation aimed to reveal the resection patterns and trends for mGC and the treatment-associated factors in Europe and the US. METHODS: Data on cases with microscopically-confirmed primary invasive stomach carcinoma with distant metastasis were obtained from the nationwide cancer registries of the Netherlands, Belgium, Norway, Sweden, Estonia, and Slovenia and the US Surveillance, Epidemiology, and End Results-18 database. We calculated age-standardized rates of primary cancer-directed resection and assessed resection trends using linear regression. We investigated associations of treatment with patient and cancer factors using multivariable-adjusted log-binomial regression. RESULTS: Among 133,321 patients with gastric cancer, overall, 40,215 cases with mGC diagnosed between 2003-2017 were investigated. Age-standardized resection rates significantly declined over time in the US, Belgium, Sweden, and Norway (by 5-14%). Resection rates greatly differed from 5% to 16% in 2013-2014. Cases with older ages, cardia tumors, or tumors involving adjacent structures were significantly less often operated across most countries. Sex was not significantly associated with resection. Across countries the association patterns and strengths differed largely. With multivariable adjustment, resection rates decreased significantly in all countries except Slovenia and Estonia (prevalence ratio per year = 0.90-0.98), and the decreasing trends were consistently observed in various stratifications by age and location. CONCLUSION: In Europe and the US, resection patterns and trends largely varied across countries for mGCs, which were mostly less often resected in the early 21st century. Various resection-associated factors were shown, with greatly varying association patterns and strengths. Our report could aid to identify discrepancies in clinical practice and highlight the great need for further clarifying the role of resection in mGCs to enhance standardization of care.
Authors: Udo Rudloff; Russell C Langan; John E Mullinax; Joal D Beane; Seth M Steinberg; Tatiana Beresnev; Carole C Webb; Melissa Walker; Mary Ann Toomey; David Schrump; Prakash Pandalai; Alexander Stojadinovic; Itzhak Avital Journal: J Surg Oncol Date: 2014-07-05 Impact factor: 3.454
Authors: Ulrike Heger; Susanne Blank; Christiane Wiecha; Rupert Langer; Wilko Weichert; Florian Lordick; Thomas Bruckner; Martin Dobritz; Maria Burian; Christoph Springfeld; Lars Grenacher; Jörg-Rüdiger Siewert; Markus Büchler; Katja Ott Journal: Ann Surg Oncol Date: 2014-01-14 Impact factor: 5.344
Authors: Yaniv Berger; Mihai Giurcanu; Charles C Vining; Darryl Schuitevoerder; Mitchell C Posner; Kevin K Roggin; Blase N Polite; Chih-Yi Liao; Oliver S Eng; Daniel V T Catenacci; Kiran K Turaga Journal: Ann Surg Oncol Date: 2021-01-08 Impact factor: 5.344
Authors: James J Mezhir; Manish A Shah; Lindsay M Jacks; Murray F Brennan; Daniel G Coit; Vivian E Strong Journal: Ann Surg Oncol Date: 2010-06-29 Impact factor: 5.344
Authors: Nikolaos Charalampakis; Graciela M Nogueras González; Elena Elimova; Roopma Wadhwa; Hironori Shiozaki; Yusuke Shimodaira; Mariela A Blum; Jane E Rogers; Kazuto Harada; Aurelio Matamoros; Tara Sagebiel; Prajnan Das; Bruce D Minsky; Jeffrey H Lee; Brian Weston; Manoop S Bhutani; Jeannelyn S Estrella; Brian D Badgwell; Jaffer A Ajani Journal: Oncology Date: 2016-04-06 Impact factor: 2.935
Authors: Sid P Kerkar; Clinton D Kemp; Austin Duffy; Udai S Kammula; David S Schrump; King F Kwong; Martha Quezado; Barry R Goldspiel; Aradhana Venkatesan; Ann Berger; Melissa Walker; Mary Ann Toomey; Seth M Steinberg; Guiseppe Giaccone; Steven A Rosenberg; Itzhak Avital Journal: Trials Date: 2009-12-23 Impact factor: 2.279
Authors: Lei Huang; Lina Jansen; Rob H A Verhoeven; Jelle P Ruurda; Liesbet Van Eycken; Harlinde De Schutter; Jan Johansson; Mats Lindblad; Tom B Johannesen; Vesna Zadnik; Tina Žagar; Sjoerd M Lagarde; Cornelis J H van de Velde; Petra Schrotz-King; Hermann Brenner Journal: Cancer Commun (Lond) Date: 2022-06-06